Cardiotoxicity Associated with Immune Checkpoint Inhibitors.
Cancers (Basel)
; 15(22)2023 Nov 20.
Article
en En
| MEDLINE
| ID: mdl-38001747
ABSTRACT
Immune checkpoint inhibitors (ICIs) have shown significant efficacy in various cancers, including non-small cell lung cancer, small cell lung cancer, melanoma, classical Hodgkin lymphoma, head and neck squamous cell carcinoma, urothelial cancer, and renal cell carcinoma [...].
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Cancers (Basel)
Año:
2023
Tipo del documento:
Article
País de afiliación:
Japón